What is BioCorRx Inc. (BICX) stock price today?

BioCorRx Inc. (BICX) is currently trading at $0.30, up 0% today.

What is BICX P/E ratio?

BioCorRx Inc.'s P/E ratio is -1.80. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BICX return on equity (ROE)?

BioCorRx Inc.'s return on equity (ROE) is 28.12%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is BioCorRx Inc.'s market cap?

BioCorRx Inc. has a market capitalization of $6.26M.

OTC · Medical - Care Facilities

BioCorRx Inc. (BICX) Stock

$0.30 +0.00% OTC: BICX Healthcare

Valuation

Metric	Value
Price	$0.30
Market Cap	$6.26M
P/E Ratio	-1.80
P/B Ratio	-0.67
P/S Ratio	7.14
EPS (TTM)	$-0.19
52-Week High	$1.28
52-Week Low	$0.20
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	28.12%
ROA	-147.53%
ROCE	78.09%
Gross Margin	83.96%
Operating Margin	-552.33%
Net Margin	-391.15%
Debt/Equity	-0.18
Current Ratio	0.12

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$1.0M
Operating Profit	$-5.0M	$-3.0M	$-4.0M	$-5.0M	$-5.0M
Net Profit	$-6.0M	$-4.0M	$-4.0M	$-5.0M	$-3.0M
EPS	$-0.89	$-0.61	$-0.45	$-0.49	$-0.19
Op Margin	-9389.9%	-1360.1%	-4248.3%	-66829.8%	-606.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$1.0M	$0	$0	$2.0M
Total Liabilities	$8.0M	$9.0M	$10.0M	$13.0M	$14.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$2.0M	$2.0M	$2.0M	$7.0M	$2.0M

Latest News

BioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and Authorized Generic (AG) SKUs to Ensure Uninterrupted Market Supply NewMediaWire · Aug 25, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-4.0M	$-2.0M	$-2.0M	$-1.0M	$-2.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$2.0M	$1.0M	$0	$0	$0
Net Cash Flow	$-1.0M	$0	$0	$0	$0
Free Cash Flow	$-4.0M	$-2.0M	$-2.0M	$-1.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.02
EV / EBITDA	-2.76
FCF Yield	-32.60%
Quick Ratio	0.10
Interest Coverage	-6.21
Return 1Y	-30.23%
Return 3Y	-86.11%
Return 5Y	—

Ownership

Insiders Held61.36%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BVAXFBioVaxys Technology Corp.	$0.11	+0.09%	-0.59	$3.27M	0.00%
FAMDFFutura Medical plc	$0.00	—	-0.15	$712597	0.00%
GBCSSelectis Health, Inc.	$5.41	+0.00%	2.69	$16.59M	0.00%
HLYKHealthLynked Corp.	$2.70	-7.25%	-2.00	$7.94M	0.00%
IONKFIonic Brands Corp.	$0.00	—	0.00	$1592	0.00%

About BioCorRx Inc.

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.

BioCorRx Inc. is headquartered in US.

BioCorRx Inc. (BICX) stock trades at $0.30 with a market capitalization of $6.26M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.80, reflecting a net loss over the last twelve months, a negative price-to-book of -0.67, reflecting negative shareholders' equity, price-to-sales of 7.14. Over the past 52 weeks the stock has ranged between $0.20 and $1.28, and currently trades 76.6% below its 52-week high.

On profitability, BioCorRx Inc. generates a return on equity (ROE) of 28.12% (not meaningful, as shareholders' equity is negative), return on capital employed of 78.09%, an operating margin of -552.33%, a net profit margin of -391.15%.

Official website: www.biocorrx.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.